Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Kozu, Yoshiki ^a   Maniwa, Tomohiro ^a   Takahashi, Shoji ^a   Isaka, Mitsuhiro ^a   Ohde, Yasuhisa ^a   Nakajima, Takashi ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Adjuvant chemotherapy; Non small cell lung cancer; Pathological stage I; Postoperative carcinoembryonic antigen level; Unfavorable prognostic factor

Indexed keywords

ANTIGEN CYFRA21.1; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; TUMOR ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMAN; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; JAPAN; KERATIN-19; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84876723540     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-106     Document Type: Article

References (26)

1. Inoue M, Minami M, Shiono H, Sawabata N, Ideguchi K, Okumura M. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. J Thorac Cardiovasc Surg 2006, 131:988-993. 10.1016/j.jtcvs.2005.12.035, 16678580.
2. Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2007, 32:435-439. 10.1016/j.ejcts.2007.05.014, 17611117.
3. Muley T, Dienemann H, Ebert W. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. Anticancer Res 2004, 24:1953-1956.
4. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg 2004, 78:216-221. 10.1016/j.athoracsur.2004.02.009, 15223432.
5. Sakao Y, Tomimitsu S, Takeda Y, Natsuaki M, Itoh T. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg 2004, 25:520-522. 10.1016/j.ejcts.2004.01.029, 15037265.
6. Sawabata N, Ohta M, Takeda S, Hirano H, Okumura Y, Asada H, Maeda H. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 2002, 74:174-179. 10.1016/S0003-4975(02)03662-7, 12118753.
7. Suzuki K, Nagai K, Yoshida J, Moriyama E, Nishimura M, Takahashi K, Nishiwaki Y. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999, 67:927-932. 10.1016/S0003-4975(99)00140-X, 10320230.
8. Yoshimasu T, Kokawa Y, Oura S, Hirai I, Sasaki R, Tanino H, Sakurai T, Okamura Y. Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence. Cancer Sci 2003, 94:741-744. 10.1111/j.1349-7006.2003.tb01512.x, 12901802.
9. Dent PB, McCulloch PB, Wesley-James O, MacLaren R, Muirhead W, Dunnett CW. Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer 1978, 42:1484-1491. 10.1002/1097-0142(197809)42:3+<1484::AID-CNCR2820420819>3.0.CO;2-J, 709519.
10. Kashiwabara K, Saeki S, Sasaki J, Nomura M, Kohrogi H. Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage I adenocarcinoma lung cancer. J Thorac Oncol 2008, 3:1416-1420. 10.1097/JTO.0b013e31818dda85, 19057266.
11. Matsuguma H, Nakahara R, Igarashi S, Ishikawa Y, Suzuki H, Miyazawa N, Honjo S, Yokoi K. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J Thorac Cardiovasc Surg 2008, 135:44-49. 10.1016/j.jtcvs.2007.09.032, 18179917.
12. Nonaka M, Kataoka D, Yamamoto S, Bito A, Matsuoka J, Kawada T, Takaba T. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma. Ann Thorac Cardiovasc Surg 2004, 10:281-284.
13. Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Cancer 2004, 101:803-809. 10.1002/cncr.20421, 15305413.
14. Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, Onitsuka T. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels. Thorac Cardiovasc Surg 2005, 53:300-304. 10.1055/s-2005-865671, 16208617.
15. Wang CY, Huang MS, Huang MH, Lee HC, Hsu HS. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer. J Surg Res 2010, 163:e45-e50. 10.1016/j.jss.2010.04.039, 20638687.
16. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-714. 10.1097/JTO.0b013e31812f3c1a, 17762336.
17. Travis WD BE, HK M-H, Harris CC. World Health Organization classification of tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart 2004, Lyon: IARC Press.
18. Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1997, 64:418-424. 10.1006/gyno.1996.4589, 9062143.
19. Kosugi S, Nishimaki T, Kanda T, Nakagawa S, Ohashi M, Hatakeyama K. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg 2004, 28:680-685.
20. Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Yang SN, Lin FJ. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix. Tumour Biol 2008, 29:255-261. 10.1159/000152943, 18781097.
21. Nagashima T, Sakao Y, Mun M, Ishikawa Y, Nakagawa K, Masuda M, Okumura S. A Clinicopathological Study of Resected Small-Sized Squamous Cell Carcinomas of the Peripheral Lung: Prognostic Significance of Serum Carcinoembryonic Antigen Levels. Ann Thorac Cardiovasc Surg 2012,
22. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H, Ochiai T. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery 2003, 133:486-494. 10.1067/msy.2003.139, 12773976.
23. Buccheri G, Ferrigno D. Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test. Ann Thorac Surg 2003, 75:973-980. 10.1016/S0003-4975(02)04638-6, 12645726.
24. Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, Wada H. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol 2005, 23:4999-5006. 10.1200/JCO.2005.09.017, 16051951.
25. Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004, 350:1713-1721. 10.1056/NEJMoa032792, 15102997.
26. Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Eur J Cardiothorac Surg 2007, 32:440-444. 10.1016/j.ejcts.2007.06.011, 17643308.